Upcoming clinical guidance

Review the topics AGA plans to release guidance on this year.

AGA guidelines in development

2022

  • Pharmacological management of IBS-C and IBS-D
  • Chronic idiopathic constipation (ACG/AGA)
  • Biomarkers for ulcerative colitis
  • Pharmacological weight loss interventions in the management of obesity

 

2023

  • Biomarkers for Crohn’s disease
  • Fecal microbiota transplantation (FMT)
  • Hepatitis B virus reactivation
  • Barrett’s esophagus
  • Lynch syndrome

AGA Clinical Practice Updates in development

2022

  • Acute kidney injury in patients with cirrhosis
  • EUS-guided gallbladder drainage in acute cholecystitis
  • Non-invasive tests (NIT) in the evaluation and management of NAFLD
  • Belching, abdominal bloating and distention
  • Refractory celiac disease
  • Extraesophageal GERD
  • Acute hepatic porphyria
  • NAFLD in lean individuals
  • Endoscopy in the management of recurrent acute pancreatitis and chronic pancreatitis
  • Implementation of novel tools for screening and surveillance of Barrett’s esophagus into clinical practice
  • Subepithelial lesions encountered during routine endoscopy
  • Short bowel syndrome
  • Exocrine pancreatic insufficiency
  • Gastric per oral endoscopic myotomy (POEM) for gastroparesis